spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  atherothrombosis 

 HSMN NewsFeed - 8 Oct 2012
Spectranetics Announces U.S. Launch of the TAPAS(TM) Catheter and Preclinical Animal Data on Drug Uptake in Peripheral Vessels
Devices Interventional Drug Delivery Distribution
 HSMN NewsFeed - 2 Jul 2012
BG Medicine, Inc. Appoints Bill Densel, General Manager, CardioSCORE
Diagnostics Cardiology Personnel
 HSMN NewsFeed - 9 Jan 2012
BG Medicine, Inc. Appoints Eric Bouvier as Chief Executive Officer
Diagnostics Personnel
 HSMN NewsFeed - 15 May 2008
Stable Stroke Patients More Likely to Die From a Nonstroke Cardiovascular Event Than a Further Stroke
Neurology
 HSMN NewsFeed - 21 Oct 2007
Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 5 Sep 2007
REACH Registry Highlights That Patients With Peripheral Arterial Disease (PAD) Suffer High Rates of Heart Attack, Stroke, Hospitalization, and Death
Cardiology
 HSMN NewsFeed - 2 Sep 2007
New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 5 Jun 2007
Health Canada's approval of an expanded indication for PLAVIX(R) (clopidogrel bisulfate) now offers protection from all types of heart attacks
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 24 Mar 2007
Schering-Plough's Novel Oral Thrombin Receptor Antagonist Meets Primary Endpoint in Phase II Trial
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 7 Sep 2006
European commission expands indication for PLAVIX® (clopidogrel bisulfate) offering new option for patients with most severe type of heart attack
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 7 Sep 2006
The New England Journal of Medicine Publishes the STEEPLE Study Which Demonstrated Superior Safety Profile of LOVENOX(R)(Enoxaparin Sodium Injection) Vs. Unfractionated Heparin in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention (PCI)
Biopharmaceuticals Interventional Cardiology
Return to NewsFeed  

 Additional items found! 10

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 10 additional stories matching:
atherothrombosis
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.